Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 5-year average of -52.47%, near the high end of its 5-year range (-17546.84%–627.71%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
-52.47%
OPERATING MARGIN AVG 10Y
-250.62%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$6.74M
Operating Margin
-450.07%
TTM Avg
-699.99%
3Y Avg
-986.00%
5Y Avg
-5433.17%
Market Cap
$7.04M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-522.59%
5Y Avg
-762.76%
Market Cap
$7.07M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-19.45%
5Y Avg
-19.45%
Market Cap
$7.12M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.15M
Operating Margin
-1942.20%
TTM Avg
-1316.46%
3Y Avg
-1768.86%
5Y Avg
-1413.19%
Market Cap
$6.61M
Operating Margin
-119.54%
TTM Avg
-108.09%
3Y Avg
-117.27%
5Y Avg
-99.55%
Market Cap
$6.60M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.60M
Operating Margin
-9312.55%
TTM Avg
-10684.89%
3Y Avg
-9259.36%
5Y Avg
-8523.06%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Exicure, Inc. (XCUR) | $6.88M | 0.00% | 0.00% | 0.00% | -52.47% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.74M | -450.07% | -699.99% | -986.00% | -5433.17% |
| KALA BIO, Inc. (KALA)vs › | $7.04M | 0.00% | 0.00% | -522.59% | -762.76% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.07M | 0.00% | 0.00% | -19.45% | -19.45% |
| Skye Bioscience, Inc. (SKYE)vs › | $7.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| Longeveron Inc. (LGVN)vs › | $7.15M | -1942.20% | -1316.46% | -1768.86% | -1413.19% |
| Biomerica, Inc. (BMRA)vs › | $6.61M | -119.54% | -108.09% | -117.27% | -99.55% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.60M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aclarion, Inc. (ACON)vs › | $6.60M | -9312.55% | -10684.89% | -9259.36% | -8523.06% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.58M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | -167.20% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 85.40% |
| 2022-09-30 | -258.18% |
| 2022-06-30 | -302.83% |
| 2022-03-31 | -301.64% |
| 2021-12-31 | -634.99% |
| 2021-09-30 | 627.71% |
| 2021-06-30 | -17546.84% |
| 2021-03-31 | -1219.36% |
| 2020-12-31 | -8900.00% |
| 2020-09-30 | -373.31% |
| 2020-06-30 | -90.57% |
| 2020-03-31 | 5.82% |
| 2019-12-31 | -3260.97% |
| 2019-09-30 | -1128.27% |
| 2019-06-30 | -1148.39% |
| 2019-03-31 | -22312.00% |
| 2018-12-31 | -81133.33% |
| 2018-09-30 | -10285.96% |
| 2018-06-30 | -30547.37% |
| 2018-03-31 | -14677.78% |
| 2017-12-31 | -141.96% |
| 2017-09-30 | -75.85% |
| 2017-06-30 | -100.78% |
| 2017-04-01 | -102.06% |
| 2016-12-31 | -788.84% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | -2155.20% |
| 2016-03-31 | -2155.20% |
